Biomedicine & Pharmacotherapy, Год журнала: 2024, Номер 180, С. 117543 - 117543
Опубликована: Окт. 14, 2024
Язык: Английский
Biomedicine & Pharmacotherapy, Год журнала: 2024, Номер 180, С. 117543 - 117543
Опубликована: Окт. 14, 2024
Язык: Английский
Chemical Engineering Journal, Год журнала: 2025, Номер unknown, С. 159276 - 159276
Опубликована: Янв. 1, 2025
Язык: Английский
Процитировано
3Pharmacological Research, Год журнала: 2024, Номер 203, С. 107150 - 107150
Опубликована: Март 21, 2024
Cancer, with its diversity, heterogeneity, and complexity, is a significant contributor to global morbidity, disability, mortality, highlighting the necessity for transformative treatment approaches. Photodynamic therapy (PDT) has aroused continuous interest as viable alternative conventional cancer treatments that encounter drug resistance. Nanotechnology brought new advances in medicine shown great potential delivery treatment. For precise efficient therapeutic utilization of such tumor approach high spatiotemporal selectivity minimal invasiveness, carrier-free noncovalent nanoparticles (NPs) based on chemo-photodynamic combination essential. Utilizing natural products foundation nanodrug development offers unparalleled advantages, including exceptional pharmacological activity, easy functionalization/modification, well biocompatibility. The natural-product-based, carrier-free, NPs revealed excellent synergistic anticancer activity comparison free photosensitizers bioactive products, representing an favorable avenue improve efficacy. Herein, comprehensive summary current strategies representative application examples past decade (such paclitaxel, 10-hydroxycamptothecin, doxorubicin, etoposide, combretastatin A4, epigallocatechin gallate, curcumin) therapy. We highlight insightful design synthesis smart aim enhance PDT Meanwhile, we discuss future challenges opportunities associated these provide enlightenment, spur innovative ideas, facilitate PDT-mediated clinical transformation.
Язык: Английский
Процитировано
15ACS Applied Nano Materials, Год журнала: 2025, Номер unknown
Опубликована: Янв. 8, 2025
Drug-resistant bacterial pneumonia presents a substantial challenge for targeted drug delivery to the infected lung site due existence of mucus and gas-blood barriers. Allicin, renowned its extensive bioactivity, holds promise as an antimicrobial agent. However, unregulated bioavailability restricts both antibacterial anti-inflammatory efficacy. As result, precise targeting infection controlled release is crucial in treatment drug-resistant pneumonia. In this study, we developed macrophage cell membrane-modified nanoallicin composite material (Allicin@MSN@CM) by utilizing membrane modification technology. By harnessing homing ability membranes inflammatory sites, enabled active aggregation nanomaterials during circulation within body. Furthermore, α-hemolysin secreted MRSA bacteria was employed perforate membrane, facilitating on-demand at site. vitro experiments demonstrated that possesses strong properties, alongside good stability biocompatibility. Additionally, mouse model infection, it not only effectively eradicated but also reduced inflammation. This study provides valuable insights into application nanocarriers delivering traditional Chinese medicine address challenges posed
Язык: Английский
Процитировано
0Materials Today Bio, Год журнала: 2025, Номер 31, С. 101557 - 101557
Опубликована: Фев. 5, 2025
Diabetic infections/wounds remain to be a threatening challenge as it seriously leads lower limb amputation with endless pains and subsequent high economic/psychosocial costs. The exceptional peroxidase-like activity of single-atom nanozymes (SAzymes) holds great promise for chemodynamic therapy (CDT) diabetic infection, but is extremely restricted by the near-neutral pH insufficient H2O2 levels in physiological conditions. Herein, we innovated hollow mesoporous molybdenum nanozyme (HMMo-zyme) featured catalytic activity, photothermal performance drug delivery properties more effective antibacterial therapeutic glucose oxidase (GOx) was encapsulated into HMMo-zyme phase-change material (PCM) form HMMo/GOx@P system, which could controllably disassembled near-infrared ray (NIR) trigger cascade CDT toward bacterial infections. results revealed that release GOx accelerated NIR facilitate continuous conversion (Glu) gluconic acid, accompanied sharply decrease establish low-pH environment notably enhanced HMMo-zyme, subsequently drives generated toxic hydroxyl radicals (·OH) amplified anti-bacterial treatment. As proof concept, this NIR-assisted strategy efficiently inhibit/kill bacteria suppress tissue inflammations, thereby accelerating wound healing processes both vitro vivo infection models. This study provides novel may serve promising alternative antibiotic therapeutics against thus holding treatment manipulating Mo-based SAzymes.
Язык: Английский
Процитировано
0Frontiers in Immunology, Год журнала: 2025, Номер 16
Опубликована: Фев. 14, 2025
Introduction Burn-induced sepsis is a critical clinical challenge marked by systemic inflammation, immune dysregulation, and high mortality. Macrophage-driven inflammatory pathways are central to pathogenesis, while cell metabolic reprogramming plays key role in both cancer progression. Methods Bioinformatics analyses using GEO, TCGA, GTEx datasets identified MLIP-modulated genes linked responses prognosis. In vitro , LPS-stimulated HUVEC cells were used study MLIP’s effects on inflammation macrophage function through viability, ROS levels, cytokine expression, qRT-PCR, immunofluorescence assays. Results associated with immune-related cancer. Epigenetic analysis showed MLIP expression regulated promoter methylation chromatin accessibility. Prognostic revealed impact survival outcomes across types. reduced oxidative stress, hyperactivation. Conclusions regulates immune-metabolic dynamics burn-induced sepsis, influencing activity stress. Its suggests as potential therapeutic target linking modulation Further research evasion tumor metabolism may inform novel strategies.
Язык: Английский
Процитировано
0Acta Biomaterialia, Год журнала: 2025, Номер unknown
Опубликована: Март 1, 2025
Язык: Английский
Процитировано
0Translational Oncology, Год журнала: 2025, Номер 55, С. 102336 - 102336
Опубликована: Апрель 1, 2025
Язык: Английский
Процитировано
0European Journal of Medicinal Chemistry, Год журнала: 2024, Номер 283, С. 117153 - 117153
Опубликована: Дек. 11, 2024
Язык: Английский
Процитировано
3European Journal of Pharmaceutical Sciences, Год журнала: 2024, Номер 195, С. 106719 - 106719
Опубликована: Фев. 1, 2024
Molecularly functional drug delivery systems possessed huge potentials to realize novel administration. To explore small molecules modified delivery, a series of mesoporous silica nanoparticles (L-Mal-MSNs, D-Mal-MSNs) were established by grafting molecules. Poorly water-soluble indomethacin (IMC) was chosen load into these carriers as well corresponding control carrier, and further study characteristics effects loaded carriers. The results indicated that all formed hydrogen bonds with drugs can successfully convert crystal phase amorphous state so enhance dissolution compared raw drug. In vivo rat intestinal perfusion demonstrated IMC L-Mal-MSNs performed the fastest absorption while analgesic anti-inflammatory D-Mal-MSNs turned out be best, giving hints D-malic acid exhibited best synergic functions for IMC. herein system is an effective solution strategy current application analgesia outstanding significance.
Язык: Английский
Процитировано
2Archiv der Pharmazie, Год журнала: 2024, Номер 357(10)
Опубликована: Июнь 20, 2024
Abstract Tetrandrine (TET) is a natural bis‐benzylisoquinoline alkaloid isolated from Stephania species with wide range of biological and pharmacologic activities; it mainly serves as an anti‐inflammatory agent or antitumor adjuvant in clinical applications. However, limitations such prominent hydrophobicity, severe off‐target toxicity, low absorption result suboptimal therapeutic outcomes preventing its widespread adoption. Nanoparticles have proven to be efficient devices for targeted drug delivery since drug‐carrying nanoparticles can passively transported the tumor site by enhanced permeability retention (EPR) effects, thus securing niche cancer therapies. Great progress has been made nanocarrier construction TET due their outstanding advantages increased water‐solubility, improved biodistribution blood circulation, reduced irritation, combinational therapy. Herein, we systematically reviewed latest advancements TET‐loaded respective features expectation providing perspective guidelines future research potential applications TET.
Язык: Английский
Процитировано
1